Details of issuance or disposal
14th Stock Acquisition Rights issued through a third-party allotment (with provisions for adjustment of the exercise price)
Number of shares delivered during the month under review: 3,435,000 new shares. Treasury shares transferred: 0 shares
The lower thin line represents the existing number of shares to which these shares will be added.
Total amount paid in: Not disclosed. Estimated net proceeds: Not disclosed
3,435,000 shares delivered during the month under review / 106,394,569 issued shares as of the end of the preceding month. Exercise ratio under the exercise restrictions: 9.99%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | 14th Stock Acquisition Rights issued through a third-party allotment (with provisions for adjustment of the exercise price) |
| Number of shares to be issued or disposed of | Number of shares delivered during the month under review: 3,435,000 new shares. Treasury shares transferred: 0 shares |
| Issue price and disposal price | Exercise price: ¥38.0 per share (exercise status during the month under review) |
| Amount of funds to be raised | Total amount paid in: Not disclosed. Estimated net proceeds: Not disclosed |
| Intended allottee | Nagasawa Makoto (長澤誠) (allottee at the time of issuance on 15 December 2023). Number of shares: Not disclosed |
| Dilution Rate | 3,435,000 shares delivered during the month under review / 106,394,569 issued shares as of the end of the preceding month. Exercise ratio under the exercise restrictions: 9.99% |
| Total number of issued shares | As of the end of the preceding month: 106,394,569 shares (including 16 treasury shares) → Not disclosed |
| Exercise price | Exercise price during the month under review: ¥38.0. Exercise price adjustment clause: applicable. Floor for adjustment: Not disclosed |
| Number of Stock Acquisition Rights | Total number issued: 187,000. Unexercised as of the end of the preceding month: 101,850. Unexercised as of the end of the month under review: 67,500 |
| Most recent equity financing | Announced on 13 November 2023: Issuance of the 11th through 13th Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause) and the 14th and 15th Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause). Amount: Not disclosed |
Items this document does not state (18)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the 14th Series of Stock Acquisition Rights in April 2026.